Pharming Group Nv logo

Pharming Group Nv Share Price Today

(NASDAQ: PHAR)

Pharming Group Nv share price is $9.2 & ₹799.09 as on 15 Feb 2025, 2.30 'hrs' IST

$9.2

0.35

(3.99%)

Market is closed - opens 8 PM, 18 Feb 2025

View live Pharming Group Nv share price in Dollar and Rupees. Guide to invest in Pharming Group Nv stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Pharming Group Nv, along with analyst recommendations, forecasts, and comprehensive financials.

Pharming Group Nv share price movements

  • Today's Low: $8.76
    Today's High: $9.20

    Day's Volatility :4.78%

  • 52 Weeks Low: $6.65
    52 Weeks High: $12.20

    52 Weeks Volatility :45.49%

Pharming Group Nv (PHAR) Returns

PeriodPharming Group NvIndex (Russel 2000)
3 Months
21.92%
0.0%
6 Months
17.65%
0.0%
1 Year
-16.44%
0.0%
3 Years
7.6%
-12.0%

Pharming Group Nv (PHAR) Key Statistics

in dollars & INR

Previous Close
$8.8467
Open
$9.06
Today's High
$9.2
Today's Low
$8.76
Market Capitalization
$624.1M
Today's Volume
$3.6K
52 Week High
$12.2
52 Week Low
$6.65
Revenue TTM
$285.7M
EBITDA
$-3.1M
Earnings Per Share (EPS)
$-0.27
Profit Margin
-6.24%
Quarterly Earnings Growth YOY
-0.61%
Return On Equity TTM
-8.18%

How to invest in Pharming Group Nv Stock (PHAR) from India?

It is very easy for Indian residents to invest directly in Pharming Group Nv from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Pharming Group Nv stock in both Indian Rupees (INR) and US Dollars (USD). Search for Pharming Group Nv or PHAR on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Pharming Group Nv or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Pharming Group Nv shares which would translate to 0.094 fractional shares of Pharming Group Nv as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Pharming Group Nv, in just a few clicks!

Returns in Pharming Group Nv (PHAR) for Indian investors in Rupees

The Pharming Group Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pharming Group Nv investment value today

Current value as on today

₹88,219

Returns

₹11,781

(-11.78%)

Returns from Pharming Group Nv Stock

₹16,440 (-16.44%)

Dollar Returns

₹4,659 (+4.66%)

Indian investors sentiment towards Pharming Group Nv (PHAR)

-52%

Period: Jan 18, 2025 to Feb 17, 2025. Change in 30 Days versus previous period

Search interest for Pharming Group Nv Stock from India on INDmoney has decreased by -52% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Pharming Group Nv

  • Silverberg Bernstein Capital Management LLC

    0.07%

Analyst Recommendation on Pharming Group Nv

Buy

    92%Buy

    7%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Pharming Group Nv(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
13
13
13
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Pharming Group Nv Stock (PHAR)

What analysts predicted

Upside of 193.48%

Target:

$27.00

Current:

$9.20

Insights on Pharming Group Nv Stock (Ticker Symbol: PHAR)

  • Price Movement

    In the last 7 days, PHAR stock has moved up by 7.5%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 55.45M → 75.06M (in $), with an average increase of 13.2% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 3 quarters, -12.41M → -1.03M (in $), with an average increase of 475.9% per quarter
  • PHAR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 74.5% return, outperforming this stock by 92.4%
  • PHAR vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 73.9% return, outperforming this stock by 66.5%
  • Price to Sales

    ForPHAR every $1 of sales, investors are willing to pay $2.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.6 for every $1 of sales.

PHAR Pharming Group Nv Financials in INR & Dollars

FY18Y/Y Change
Revenue
$154.6M
↑ 43.77%
Net Income
$28.6M
↓ 129.8%
Net Profit Margin
18.5%
↑ 107.72%
FY19Y/Y Change
Revenue
$189.3M
↑ 22.49%
Net Income
$40.5M
↑ 41.82%
Net Profit Margin
21.41%
↑ 2.91%
FY20Y/Y Change
Revenue
$228.4M
↑ 20.63%
Net Income
$37.7M
↓ 6.9%
Net Profit Margin
16.53%
↓ 4.88%
FY21Y/Y Change
Revenue
$189.9M
↓ 16.88%
Net Income
$16.0M
↓ 57.62%
Net Profit Margin
8.43%
↓ 8.1%
FY22Y/Y Change
Revenue
$205.6M
↑ 8.31%
Net Income
$13.7M
↓ 14.52%
Net Profit Margin
6.65%
↓ 1.78%
FY23Y/Y Change
Revenue
$245.3M
↑ 19.3%
Net Income
$-10.5M
↓ 177.14%
Net Profit Margin
-4.3%
↓ 10.95%
Q2 FY23Q/Q Change
Revenue
$54.9M
↑ 0.51%
Net Income
$1.3M
↓ 109.02%
Net Profit Margin
2.4%
↑ 29.18%
Q3 FY23Q/Q Change
Revenue
$66.7M
↑ 21.43%
Net Income
$3.5M
↑ 162.62%
Net Profit Margin
5.2%
↑ 2.8%
Q4 FY23Q/Q Change
Revenue
$81.9M
↑ 22.81%
Net Income
$-2.7M
↓ 178.58%
Net Profit Margin
-3.33%
↓ 8.53%
Q1 FY24Q/Q Change
Revenue
$55.5M
↓ 32.26%
Net Income
$-12.4M
↑ 356.21%
Net Profit Margin
-22.39%
↓ 19.06%
Q2 FY24Q/Q Change
Revenue
$74.0M
↑ 33.5%
Net Income
$-1.2M
↓ 90.35%
Net Profit Margin
-1.62%
↑ 20.77%
Q3 FY24Q/Q Change
Revenue
$75.1M
↑ 1.39%
Net Income
$-1.0M
↓ 13.75%
Net Profit Margin
-1.38%
↑ 0.24%
FY18Y/Y Change
Profit
$129.2M
↑ 39.55%
FY19Y/Y Change
Profit
$165.4M
↑ 28.02%
FY20Y/Y Change
Profit
$203.1M
↑ 22.76%
FY21Y/Y Change
Profit
$169.7M
↓ 16.44%
FY22Y/Y Change
Profit
$188.1M
↑ 10.84%
FY23Y/Y Change
Profit
$220.1M
↑ 17.04%
Q2 FY23Q/Q Change
Profit
$49.2M
↑ 1.71%
Q3 FY23Q/Q Change
Profit
$58.4M
↑ 18.7%
Q4 FY23Q/Q Change
Profit
$74.7M
↑ 28.0%
Q1 FY24Q/Q Change
Profit
$47.1M
↓ 36.97%
Q2 FY24Q/Q Change
Profit
$66.0M
↑ 40.24%
Q3 FY24Q/Q Change
Profit
$68.2M
↑ 3.31%
FY18Y/Y Change
Operating Cash Flow
$46.2M
↑ 0.75%
Investing Cash Flow
$-3.8M
↓ 37.65%
Financing Cash Flow
$-20.5M
↑ 426.13%
FY19Y/Y Change
Operating Cash Flow
$74.6M
↑ 61.42%
Investing Cash Flow
$-25.2M
↑ 569.06%
Financing Cash Flow
$-62.3M
↑ 203.33%
FY20Y/Y Change
Operating Cash Flow
$91.0M
↑ 22.03%
Investing Cash Flow
$-13.7M
↓ 45.76%
Financing Cash Flow
$65.3M
↓ 204.82%
FY21Y/Y Change
Operating Cash Flow
$36.1M
↓ 60.29%
Investing Cash Flow
$-18.0M
↑ 31.33%
Financing Cash Flow
$-26.7M
↓ 140.84%
FY22Y/Y Change
Operating Cash Flow
$22.9M
↓ 36.62%
Investing Cash Flow
$5.3M
↓ 129.63%
Financing Cash Flow
$-5.0M
↓ 81.33%
Q2 FY23Q/Q Change
Operating Cash Flow
$-9.6M
↓ 269.56%
Investing Cash Flow
$20.3M
↓ 9546.05%
Financing Cash Flow
$-2.6M
↓ 1045.68%

Pharming Group Nv Technicals Summary

Sell

Neutral

Buy

Pharming Group Nv is currently in a neutral trading position according to technical analysis indicators.

Pharming Group Nv (PHAR) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Pharming Group Nv logo
-3.66%
17.65%
-16.44%
7.6%
-44.91%
Biontech Se logo
2.2%
35.36%
31.33%
-20.05%
270.07%
Regeneron Pharmaceuticals, Inc. logo
-2.06%
-43.5%
-28.86%
11.73%
68.76%
Vertex Pharmaceuticals Incorporated logo
7.27%
-5.82%
9.12%
99.38%
87.27%
Alnylam Pharmaceuticals, Inc. logo
-3.22%
-8.66%
71.32%
74.68%
92.65%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Pharming Group Nv logo
NA
NA
NA
-0.01
-0.08
-0.01
NA
0.44
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
17.57
17.57
0.99
43.2
0.16
0.07
NA
273.57
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.27
18.13
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.84
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Pharming Group Nv logo
Buy
$624.1M
-44.91%
NA
-6.24%
Biontech Se logo
Buy
$29.4B
270.07%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.7B
68.76%
17.57
31.07%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.8B
87.27%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$34.3B
92.65%
NA
-12.37%

About Pharming Group Nv

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Organization
Pharming Group Nv
Employees
382
CEO
Dr. Sijmen de Vries M.B.A., M.D.
Industry
Miscellaneous

Management People of Pharming Group Nv

NameTitle
Dr. Sijmen de Vries M.B.A., M.D.
President, CEO & Executive Director
Mr. Jeroen Wakkerman
Chief Financial Officer
Ms. Mireille Sanders M.Sc.
Chief Operations Officer
Ms. Susanne Embleton
Investor Relations Manager
Mr. Ruud Van Outersterp
Chief Ethics & Compliance Officer
Ms. Ines Bernal
Chief People Officer
Dr. Anurag Relan M.D., MPH
Chief Medical Officer
Mr. Stephen Toor
Chief Commercial Officer & GM Americas
Dr. Alexander Breidenbach M.B.A.
Chief Business Officer
Dr. Bruno M. L. Giannetti
Consultant

Important FAQs about investing in PHAR Stock from India :

What is Pharming Group Nv share price today?

Pharming Group Nv share price today stands at $9.20, Open: $9.06 ; Previous Close: $8.85 ; High: $9.20 ; Low: $8.76 ; 52 Week High: $12.20 ; 52 Week Low: $6.65.

The stock opens at $9.06, after a previous close of $8.85. The stock reached a daily high of $9.20 and a low of $8.76, with a 52-week high of $12.20 and a 52-week low of $6.65.

Can Indians buy Pharming Group Nv shares?

Yes, Indians can invest in the Pharming Group Nv (PHAR) from India.

With INDmoney, you can buy Pharming Group Nv at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Pharming Group Nv at zero transaction cost.

How can I buy Pharming Group Nv shares from India?

It is very easy to buy Pharming Group Nv from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Pharming Group Nv (PHAR) be purchased?

Yes, you can buy fractional shares of Pharming Group Nv with INDmoney app.

What are the documents required to start investing in Pharming Group Nv stocks?

To start investing in Pharming Group Nv, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Pharming Group Nv Stock (PHAR)?

Today’s highest price of Pharming Group Nv (PHAR) is $9.20.

Today’s lowest price of Pharming Group Nv (PHAR) is $8.76.

What is today's market capitalisation of Pharming Group Nv?

Today's market capitalisation of Pharming Group Nv PHAR is 624.1M

What is the 52 Week High and Low Range of Pharming Group Nv Stock (PHAR)?

  • 52 Week High

    $12.20

  • 52 Week Low

    $6.65

What are the historical returns of Pharming Group Nv (PHAR)?

  • 1 Month Returns

    -3.66%

  • 3 Months Returns

    17.65%

  • 1 Year Returns

    -16.44%

  • 5 Years Returns

    -44.91%

Who is the Chief Executive Officer (CEO) of Pharming Group Nv ?

Dr. Sijmen de Vries M.B.A., M.D. is the current Chief Executive Officer (CEO) of Pharming Group Nv.